Although the exact mechanisms of SIRT1 in the pathogenesis of MS are not fully understood and are controversial, it is hypothesized that SIRT1 dysregulation may have an impact on the development and progression of MS. This evidence concerns the gene SIRT1 and myeloid sarcoma.